Artificial disc device from AxioMed nears trial completion

01/11/2013 | MedCityNews.com

AxioMed Spine expects to complete a pivotal U.S. study of its Freedom Lumbar Disc, which is used to treat patients suffering from degenerative spine disease, before the end of the quarter. The Cleveland company, which has secured $3.6 million in its latest funding round, will use data from the trial to back its FDA clearance application for the device.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC